These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7989921)

  • 41. Treatment of depersonalization with serotonin reuptake blockers.
    Hollander E; Liebowitz MR; DeCaria C; Fairbanks J; Fallon B; Klein DF
    J Clin Psychopharmacol; 1990 Jun; 10(3):200-3. PubMed ID: 2115893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The improvement of obsessive- compulsive symptoms in a patient with schizophrenia treated with clozapine.
    Kumar S; Ng B; Howie W
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):235-6. PubMed ID: 12667173
    [No Abstract]   [Full Text] [Related]  

  • 43. Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.
    Hollander E; DeCaria CM; Schneier FR; Schneier HA; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1990 Mar; 51(3):119-23. PubMed ID: 2106515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluoxetine as an adjunct to conventional antipsychotic treatment of schizophrenia patients with residual symptoms.
    Arango C; Kirkpatrick B; Buchanan RW
    J Nerv Ment Dis; 2000 Jan; 188(1):50-3. PubMed ID: 10665462
    [No Abstract]   [Full Text] [Related]  

  • 45. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms.
    Rodriguez CI; Corcoran C; Simpson HB
    Am J Psychiatry; 2010 Jul; 167(7):754-61. PubMed ID: 20595428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pharmacotherapy of moral or religious scrupulosity.
    Fallon BA; Liebowitz MR; Hollander E; Schneier FR; Campeas RB; Fairbanks J; Papp LA; Hatterer JA; Sandberg D
    J Clin Psychiatry; 1990 Dec; 51(12):517-21. PubMed ID: 2258366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder.
    Hollander E; Stein DJ; DeCaria CM; Saoud JB; Klein DF; Liebowitz MR
    Biol Psychiatry; 1993 May; 33(10):747-9. PubMed ID: 8353170
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of schizophrenia with obsessive-compulsive features.
    Hwang MY; Kim SW; Yum SY; Opler LA
    Psychiatr Clin North Am; 2009 Dec; 32(4):835-51. PubMed ID: 19944887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Price LH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discontinuing obsessive-compulsive disorder medication with behavior therapy.
    Baer L; Ricciardi J; Keuthen N; Pettit AR; Buttolph ML; Otto M; Minichiello W; Jenike MA
    Am J Psychiatry; 1994 Dec; 151(12):1842. PubMed ID: 7977900
    [No Abstract]   [Full Text] [Related]  

  • 53. Buspirone in obsessive-compulsive disorder.
    Maruno CA; Hart LL
    Ann Pharmacother; 1992 Oct; 26(10):1248-51. PubMed ID: 1421651
    [No Abstract]   [Full Text] [Related]  

  • 54. Schizophrenia and obsessive-compulsive disorder.
    Devulapalli K; Nasrallah HA
    Am J Psychiatry; 2010 Nov; 167(11):1407-8. PubMed ID: 21041254
    [No Abstract]   [Full Text] [Related]  

  • 55. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo.
    Baker RW; Ames D; Umbricht DS; Chengappa KN; Schooler NR
    Psychopharmacol Bull; 1996; 32(1):89-93. PubMed ID: 8927681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The mental disorder and obsessive-compulsive spectrum disorders in childhood ].
    Okada T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):992-8. PubMed ID: 22292193
    [No Abstract]   [Full Text] [Related]  

  • 57. Effectiveness of aripiprazole in treating obsessive compulsive symptoms.
    Yang KC; Su TP; Chou YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):585-6. PubMed ID: 18037548
    [No Abstract]   [Full Text] [Related]  

  • 58. Aggravation of schizophrenia by clomipramine in a patient with comorbid obsessive-compulsive disorder.
    Margetić B; Aukst-Margetić B; Jakovljević M
    Psychopharmacol Bull; 2008; 41(2):9-11. PubMed ID: 18668013
    [No Abstract]   [Full Text] [Related]  

  • 59. Management of treatment-refractory obsessive compulsive disorder patients.
    Dominguez RA; Mestre SM
    J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoxetine and schizophrenia in a patient with obsessional thinking.
    Baker RW
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):232-3. PubMed ID: 1627986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.